Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Cytotoxic effect caspase activation dependent of a genetically engineered fusion protein with a CD154 peptide mimetic (OmpC-CD154p) on B-NHL cell lines is mediated by the inhibition of bcl-6 and YY1 through MAPK p38 activation.

Pantoja-Escobar G, Morales-Martínez M, Vega GG, Castro-Escarpulli G, Vega MI.

Leuk Lymphoma. 2018 Oct 2:1-9. doi: 10.1080/10428194.2018.1516286. [Epub ahead of print]

PMID:
30277117
2.

Dual role of hypoxia-inducible factor 1 α in experimental pulmonary tuberculosis: its implication as a new therapeutic target.

Baay-Guzman GJ, Duran-Padilla MA, Rangel-Santiago J, Tirado-Rodriguez B, Antonio-Andres G, Barrios-Payan J, Mata-Espinosa D, Klunder-Klunder M, Vega MI, Hernandez-Pando R, Huerta-Yepez S.

Future Microbiol. 2018 Jun 1;13:785-798. doi: 10.2217/fmb-2017-0168. Epub 2018 May 31.

PMID:
29848058
3.

Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene.

Antonio-Andrés G, Rangel-Santiago J, Tirado-Rodríguez B, Martinez-Ruiz GU, Klunder-Klunder M, Vega MI, Lopez-Martinez B, Jiménez-Hernández E, Torres Nava J, Medina-Sanson A, Huerta-Yepez S.

Leuk Lymphoma. 2018 Apr 4:1-11. doi: 10.1080/10428194.2018.1448083. [Epub ahead of print]

PMID:
29616858
4.

Characterization of the novel HLA allele: B*14:58.

Ingrassia F, Mistretta S, Bavetta R, Vega MI, Cappuzzo V.

HLA. 2018 Apr;91(4):297-298. doi: 10.1111/tan.13225.

PMID:
29381261
5.

[Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression.

Hernandez-Cueto A, Hernandez-Cueto D, Antonio-Andres G, Mendoza-Marin M, Jimenez-Gutierrez C, Sandoval-Mejia AL, Mora-Campos R, Gonzalez-Bonilla C, Vega MI, Bonavida B, Huerta-Yepez S.

Mol Med Rep. 2017 Oct;16(4):5738. doi: 10.3892/mmr.2017.7234. Epub 2017 Aug 11.

6.

Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells.

Negrette-Guzmán M, Huerta-Yepez S, Vega MI, León-Contreras JC, Hernández-Pando R, Medina-Campos ON, Rodríguez E, Tapia E, Pedraza-Chaverri J.

Food Chem Toxicol. 2017 Feb;100:90-102. doi: 10.1016/j.fct.2016.12.020. Epub 2016 Dec 18.

PMID:
27993529
7.

A novel role of Yin-Yang-1 in pulmonary tuberculosis through the regulation of the chemokine CCL4.

Rangel-Santiago JF, Baay-Guzman GJ, Duran-Padilla MA, Lopez-Bochm KA, Garcia-Romero BL, Hernandez-Cueto DD, Pantoja-Escobar G, Vega MI, Hernandez-Pando R, Huerta-Yepez S.

Tuberculosis (Edinb). 2016 Jan;96:87-95. doi: 10.1016/j.tube.2015.10.013. Epub 2015 Nov 30.

PMID:
26786659
8.

Intraspecific variation in essential oil composition of the medicinal plant Lippia integrifolia (Verbenaceae). Evidence for five chemotypes.

Marcial G, de Lampasona MP, Vega MI, Lizarraga E, Viturro CI, Slanis A, Juárez MA, Elechosa MA, Catalán CAN.

Phytochemistry. 2016 Feb;122:203-212. doi: 10.1016/j.phytochem.2015.11.004. Epub 2015 Nov 19.

PMID:
26608668
9.

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma.

Vega GG, Avilés-Salas A, Chalapud JR, Martinez-Paniagua M, Pelayo R, Mayani H, Hernandez-Pando R, Martinez-Maza O, Huerta-Yepez S, Bonavida B, Vega MI.

BMC Cancer. 2015 Oct 16;15:722. doi: 10.1186/s12885-015-1778-8.

10.

Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy.

Vega GG, Franco-Cea LA, Huerta-Yepez S, Mayani H, Morrison SL, Bonavida B, Vega MI.

Int J Oncol. 2015 Nov;47(5):1735-48. doi: 10.3892/ijo.2015.3170. Epub 2015 Sep 16.

11.

Inhibition of tumor progression during allergic airway inflammation in a murine model: significant role of TGF-β.

Tirado-Rodriguez B, Baay-Guzman G, Hernandez-Pando R, Antonio-Andres G, Vega MI, Rocha-Zavaleta L, Bonifaz LC, Huerta-Yepez S.

Cancer Immunol Immunother. 2015 Sep;64(9):1205-14. doi: 10.1007/s00262-015-1722-4. Epub 2015 Jun 16.

12.

Integrated life-cycle assessment of electricity-supply scenarios confirms global environmental benefit of low-carbon technologies.

Hertwich EG, Gibon T, Bouman EA, Arvesen A, Suh S, Heath GA, Bergesen JD, Ramirez A, Vega MI, Shi L.

Proc Natl Acad Sci U S A. 2015 May 19;112(20):6277-82. doi: 10.1073/pnas.1312753111. Epub 2014 Oct 6.

13.

Death receptor 5 expression is inversely correlated with prostate cancer progression.

Hernandez-Cueto A, Hernandez-Cueto D, Antonio-Andres G, Mendoza-Marin M, Jimenez-Gutierrez C, Sandoval-Mejia AL, Mora-Campos R, Gonzalez-Bonilla C, Vega MI, Bonavida B, Huerta-Yepez S.

Mol Med Rep. 2014 Nov;10(5):2279-86. doi: 10.3892/mmr.2014.2504. Epub 2014 Aug 21.

14.

Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.

Huerta-Yepez S, Liu H, Baritaki S, Del Lourdes Cebrera-Muñoz M, Rivera-Pazos C, Maldonado-Valenzuela A, Valencia-Hipolito A, Vega MI, Chen H, Berenson JR, Bonavida B.

Int J Oncol. 2014 Sep;45(3):1184-92. doi: 10.3892/ijo.2014.2511. Epub 2014 Jun 20.

PMID:
24970600
15.

Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to Apoptosis.

Bonavida B, Jazirehi A, Vega MI, Huerta-Yepez S, Baritaki S.

For Immunopathol Dis Therap. 2013;4(1). doi: 10.1615/ForumImmunDisTher.2013008299.

16.

Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.

Valencia-Hipόlito A, Hernández-Atenógenes M, Vega GG, Maldonado-Valenzuela A, Ramon G, Mayani H, Peña Alonso Y, Martinez-Maza O, Méndez-Tenorio A, Huerta-Yepez S, Bonavida B, Vega MI.

Leuk Lymphoma. 2014 Aug;55(8):1806-14. doi: 10.3109/10428194.2013.848437. Epub 2014 Feb 6.

PMID:
24067139
17.

Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabine.

Hariharan K, Chu P, Murphy T, Clanton D, Berquist L, Molina A, Ho SN, Vega MI, Bonavida B.

Int J Oncol. 2013 Aug;43(2):670-6. doi: 10.3892/ijo.2013.1986. Epub 2013 Jun 13.

18.

Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.

Huerta-Yepez S, Baritaki S, Baay-Guzman G, Hernandez-Luna MA, Hernandez-Cueto A, Vega MI, Bonavida B.

Nitric Oxide. 2013 Feb 28;29:17-24. doi: 10.1016/j.niox.2012.12.001. Epub 2012 Dec 11.

PMID:
23246440
19.

Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL.

Hernandez-Luna MA, Rocha-Zavaleta L, Vega MI, Huerta-Yepez S.

Leuk Lymphoma. 2013 May;54(5):1048-55. doi: 10.3109/10428194.2012.733874. Epub 2012 Oct 19.

PMID:
23013270
20.

HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation.

Baay-Guzman GJ, Bebenek IG, Zeidler M, Hernandez-Pando R, Vega MI, Garcia-Zepeda EA, Antonio-Andres G, Bonavida B, Riedl M, Kleerup E, Tashkin DP, Hankinson O, Huerta-Yepez S.

Respir Res. 2012 Jul 23;13:60. doi: 10.1186/1465-9921-13-60.

21.

Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.

Martinez-Paniagua MA, Vega MI, Huerta-Yepez S, Baritaki S, Vega GG, Hariharan K, Bonavida B.

Mol Cancer Ther. 2012 Mar;11(3):572-81. doi: 10.1158/1535-7163.MCT-11-0635. Epub 2012 Jan 19.

22.

Role of CXCL13 in asthma: novel therapeutic target.

Baay-Guzman GJ, Huerta-Yepez S, Vega MI, Aguilar-Leon D, Campillos M, Blake J, Benes V, Hernandez-Pando R, Teran LM.

Chest. 2012 Apr;141(4):886-894. doi: 10.1378/chest.11-0633. Epub 2011 Oct 20.

PMID:
22016489
23.

Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis.

Martínez-Paniagua MA, Baritaki S, Huerta-Yepez S, Ortiz-Navarrete VF, González-Bonilla C, Bonavida B, Vega MI.

Cell Cycle. 2011 Aug 15;10(16):2792-805. Epub 2011 Aug 15.

24.

Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival.

Huerta-Yepez S, Yoon NK, Hernandez-Cueto A, Mah V, Rivera-Pazos CM, Chatterjee D, Vega MI, Maresh EL, Horvath S, Chia D, Bonavida B, Goodglick L.

BMC Cancer. 2011 Jun 21;11:259. doi: 10.1186/1471-2407-11-259.

25.

Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis.

Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, Riedl M, Diaz-Sanchez D, Kleerup E, Tashkin DP, Gonzalez FJ, Bonavida B, Zeidler M, Hankinson O.

Allergy. 2011 Jul;66(7):909-18. doi: 10.1111/j.1398-9995.2011.02594.x. Epub 2011 Apr 26.

26.

A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.

Vega MI, Baritaki S, Huerta-Yepez S, Martinez-Paniagua MA, Bonavida B.

Leuk Lymphoma. 2011 Jan;52(1):108-21. doi: 10.3109/10428194.2010.531408. Epub 2010 Dec 6.

PMID:
21133714
27.

Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.

Vega MI, Martínez-Paniagua M, Huerta-Yepez S, González-Bonilla C, Uematsu N, Bonavida B.

Int J Oncol. 2009 Dec;35(6):1289-96.

PMID:
19885551
28.

Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.

Vega MI, Huerta-Yepez S, Martinez-Paniagua M, Martinez-Miguel B, Hernandez-Pando R, González-Bonilla CR, Chinn P, Hanna N, Hariharan K, Jazirehi AR, Bonavida B.

Clin Cancer Res. 2009 Nov 1;15(21):6582-94. doi: 10.1158/1078-0432.CCR-09-1234. Epub 2009 Oct 27.

29.

The NF-kappaB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugs.

Vega MI, Martinez-Paniagua M, Jazirehi AR, Huerta-Yepez S, Umezawa K, Martinez-Maza O, Bonavida B.

Leuk Lymphoma. 2008 Oct;49(10):1982-94. doi: 10.1080/10428190802357071.

PMID:
18949621
30.

2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model.

Huerta-Yepez S, Baay-Guzman GJ, Garcia-Zepeda R, Hernandez-Pando R, Vega MI, Gonzalez-Bonilla C, Bonavida B.

Clin Immunol. 2008 Nov;129(2):313-24. doi: 10.1016/j.clim.2008.07.023. Epub 2008 Sep 14.

PMID:
18793875
31.

Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.

Bonavida B, Baritaki S, Huerta-Yepez S, Vega MI, Chatterjee D, Yeung K.

Nitric Oxide. 2008 Sep;19(2):152-7. doi: 10.1016/j.niox.2008.04.018. Epub 2008 Apr 24. Review.

PMID:
18477483
32.
33.

Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.

Vega MI, Huerta-Yepez S, Jazirehi AR, Garban H, Bonavida B.

Oncogene. 2005 Dec 8;24(55):8114-27.

PMID:
16103877
35.

Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.

Bonavida B, Vega MI.

Drug Resist Updat. 2005 Feb-Apr;8(1-2):27-41. Epub 2005 Apr 8. Review.

PMID:
15939340
36.
37.

Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.

Vega MI, Huerta-Yepaz S, Garban H, Jazirehi A, Emmanouilides C, Bonavida B.

Oncogene. 2004 Apr 29;23(20):3530-40.

PMID:
15077178
38.

A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.

Vega MI, Santos-Argumedo L, Huerta-Yepez S, Luría-Perez R, Ortiz-Navarrete V, Isibasi A, González-Bonilla CR.

Immunology. 2003 Oct;110(2):206-16.

39.

Identification of heptadecanoic and C19 cyclopropane fatty acids in the lipid fraction of Zymomonas mobilis.

Vega MI, Cuenca MR, Rodríguez E, Callieri D.

Curr Microbiol. 2000 Oct;41(4):305-6.

PMID:
10977901

Supplemental Content

Support Center